POST ACUTE MEDICAL AT ALLEN — History
CCN 673025 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$35M
Latest Revenue (FY2022)
+22.9%
Revenue CAGR (3yr)
22.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $23M | $33M | $35M | +4.4% | +22.9% |
| Operating Expenses | $21M | $26M | $27M | +5.1% | +13.6% |
| Operating Margin | 9.2% | 23.0% | 22.4% | -2.3% | +56.0% |
| Net Income | $2M | $8M | $8M | +2.0% | +91.7% |
| Licensed Beds | 56 | 56 | 56 | +0.0% | +0.0% |
| Total Patient Days | 13,670 | 17,872 | 18,016 | +0.8% | +14.8% |
| Medicare Day % | 68% | 71% | 71% | +0.4% | +2.3% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +51.0% ($23M → $35M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+22.9%
This Hospital
+7.6%
State Avg
Latest Margin
22.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $40M | 29.1% |
| FY2024 (proj) | $46M | 35.7% |
| FY2025 (proj) | $52M | 42.3% |